We're investing in the Beech Band, a wearable device that aims to manage Parkinson's symptoms Date 20 September 2024 The Beech Band, designed by Carl Beech, is a wearable device showing promising signs of being able to manage symptoms including speech issues, anxiety and gait.
Progress towards a form of adaptable deep brain stimulation Date 19 August 2024 A small study shows that adaptive deep brain stimulation is better than the standard version at controlling movement symptoms day and night for people with Parkinson’s.
Parkinson's UK invests in developing potential new drug with Acurex Biosciences Date 7 August 2024 We're investing £1.6m through our Virtual Biotech programme to drive forward the development of a promising molecule which has the potential to become a drug that slows or stops Parkinson’s.
Results from major study of speech and language therapy for Parkinson’s published Date 11 July 2024 The results found that Lee Silverman Voice Treatment (LSVT LOUD) is more effective than NHS speech and language therapy.
Parkinson’s UK invests in clinical trial of a potential treatment that could protect brain cells Date 2 July 2024 We're providing £1.24m through our Virtual Biotech programme to help test a potential treatment called MTX325 in people with Parkinson’s.
Parkinson's UK invests in first trial of pioneering treatment in people with Parkinson’s Date 1 July 2024 We're providing £1.55m through our Virtual Biotech programme to carry out the first clinical trials to see if HER-096 is safe for people with Parkinson’s and to start exploring its potential benefits.
Caption Researcher in a laboratory £100,000 awarded for research looking at new drug target for Parkinson’s Date 26 June 2024 Parkinson's UK is funding researchers to develop a potential set of drugs against a new target for people with Parkinson's.
Caption test samples in tubes Blood test shows promise for identifying Parkinson’s before movement symptoms Date 18 June 2024 Research co-funded by Parkinson’s UK finds a new way to potentially improve diagnosis and monitoring of Parkinson’s.
Parkinson's UK invests in development of potential new drugs to protect brain cells using mitochondria Date 5 June 2024 We're providing £1.6m through our Virtual Biotech programme to develop a potential new treatment targeting mitochondria to protect brain cells in Parkinson's patients.
Caption Photo by Aurore Delsoir Photography Prize for work ensuring patient voice is included in research Date 31 May 2024 A partnership involving Parkinson’s UK has been recognised at the Made with Patients awards, organised by Patient Focused Medicines Development.
